Endogenous soluble receptors sBCMA and sTACI: biomarker, immunoregulator and hurdle for therapy in multiple myeloma

MLA

Edgar Meinl, and Markus Krumbholz. “Endogenous Soluble Receptors SBCMA and STACI: Biomarker, Immunoregulator and Hurdle for Therapy in Multiple Myeloma.” Current Opinion in Immunology, vol. 71, Aug. 2021, pp. 117–23. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....145cb05d63f9953348aa27088b18527a&authtype=sso&custid=ns315887.

APA

Edgar Meinl, & Markus Krumbholz. (2021). Endogenous soluble receptors sBCMA and sTACI: biomarker, immunoregulator and hurdle for therapy in multiple myeloma. Current Opinion in Immunology, 71, 117–123.

Chicago

Edgar Meinl, and Markus Krumbholz. 2021. “Endogenous Soluble Receptors SBCMA and STACI: Biomarker, Immunoregulator and Hurdle for Therapy in Multiple Myeloma.” Current Opinion in Immunology 71 (August): 117–23. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....145cb05d63f9953348aa27088b18527a&authtype=sso&custid=ns315887.